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Mucosal-associated invariant T cells promote
inflammation and intestinal dysbiosis leading to
metabolic dysfunction during obesity
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Obesity is associated with low-grade chronic inflammation promoting insulin-resistance and
diabetes. Gut microbiota dysbiosis is a consequence as well as a driver of obesity and
diabetes. Mucosal-associated invariant T cells (MAIT) are innate-like T cells expressing a
semi-invariant T cell receptor restricted to the non-classical MHC class I molecule MR1
presenting bacterial ligands. Here we show that during obesity MAIT cells promote inflam-
mation in both adipose tissue and ileum, leading to insulin resistance and impaired glucose
and lipid metabolism. MAIT cells act in adipose tissue by inducing M1 macrophage polar-
ization in an MR1-dependent manner and in the gut by inducing microbiota dysbiosis and loss
of gut integrity. Both MAIT cell-induced tissue alterations contribute to metabolic dysfunc-
tion. Treatment with MAIT cell inhibitory ligand demonstrates its potential as a strategy
against inflammation, dysbiosis and metabolic disorders.
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Obesity is characterized by a chronic low-grade inflam-mation of the visceral adipose tissue (VAT), and thisinflammation is a major driver of insulin resistance
associated with the development of type 2 diabetes (T2D)1–5.
VAT inflammation in obesity is the result of tissue accumulation
of pro-inflammatory immune cells that include M1 macrophages,
CD8+ T cells, Th17 CD4+ T cells, NK cells, and neutrophils6–11.
In contrast, there is a reduction in the frequency of anti-
inflammatory immune cells such as M2 macrophages, Foxp3+-
regulatory T cells (Treg), eosinophils, and type 2 innate lymphoid
cells (ILC2) that are associated with protection against
insulin resistance through local control of inflammation in
VAT8,12–16.
Gut mucosa contains many immune cells, as it is continually
exposed to microbial antigens and ingested antigens from the
diet17–20. Obesity promotes a pro-inflammatory shift in gut
immune cell populations, characterized by reduced Foxp3+ Treg
cells in the lamina propria and an increase of IFN-γ-producing
Th1 and CD8+ T cells and IL-17-producing γδ T cells21–24.
Obesity is also associated with changes in gastrointestinal flora,
and microbiota transfer from obese patients or mice can impact
body fat expansion, systemic inflammation, and insulin
resistance25–28.
Mucosal-associated invariant T (MAIT) cells are innate-like
T cells that typically express an invariant TCR α-chain (Vα7.2-
Jα33 in humans and Vα19-Jα33 in mice), with a limited number
of β-chains29–31. MAIT cells recognize the major histo-
compatibility complex-related molecule 1 (MR1), presenting
antigens from certain bacteria and yeast31,32. MAIT cell anti-
gens derive from bacterial metabolites of vitamin
B2 synthesis33,34. We and others have revealed major MAIT cell
alterations in T2D and obese patients35–37. In these patients,
MAIT cells are less abundant in blood and they produce high
level of IL-17 in VAT. Moreover, bariatric surgery-induced
weight loss and associated improvement of metabolic and
inflammatory status were accompanied by a significant increase
of blood MAIT cell frequency36. All these observations
prompted us to investigate the role of MAIT cells during obe-
sity and T2D in mouse models.
We first analyzed MAIT cell alteration occurring in obese
C57BL/6J (B6) mice, which were either fed high-fat diet (HFD) or
deficient for leptin (ob/ob mice), then we deciphered the impact
of MAIT cells in obesity using Vα19 transgenic B6 mice
expressing elevated frequency of MAIT cells and MR1−/− B6
mice devoid of MAIT cells. We analyzed glucose and lipid
metabolism, inflammation status of VAT and ileum, immune cell
populations in these tissues, and gut microbiota composition. We
also assessed the therapeutic potential of blocking MAIT cells
function with a non-activating ligand. Together our results
revealed a deleterious role of MAIT cells in the development of
metabolic dysfunction, which involved macrophage M polariza-
tion in adipose tissue as well as dysbiosis and gut leakiness.
Results
Impaired MAIT cell accumulation in adipose tissue and ileum.
We first analyzed the frequency of MAIT cells in several tissues from
B6 mice fed either HFD or normal diet (ND) for 12 weeks. Using
mouse MR1 tetramers loaded with 5-OP-RU (TetMR1+)38,39,
MAIT cells were identified as CD45+CD19-CD11b-TCRγδ−
TCRαβ+TetMR1+ (Fig. 1a). As previously observed in obese and
T2D patients, MAIT cell frequency was decreased in the blood of
obese B6 mice compared with lean mice (Fig. 1a, b). MAIT cell
frequency was also decreased in epididymal adipose tissue (Epi-AT)
and ileum from obese mice compared with lean mice, whereas
MAIT cell frequency remained unchanged in the spleen, liver, and
colon. Of note, decreased frequency of MAIT cells in Epi-AT and
ileum was also observed in terms of absolute numbers (Fig. 1c). In
these tissues, most MAIT cells are CD4−CD8α− (>80% of total
MAIT cells), and this proportion was not modified under HFD
(Supplementary Fig. 1a). Since obesity can induce early modification
of immune cell homeostasis in adipose tissue and gut24,40,41, we
performed a kinetic analysis of MAIT cell frequency in these tissues
(Fig. 1d). No significant differences were observed at 6 weeks after
beginning of HFD; however, differences observed at 12 weeks after
HFD were sustained after 16 weeks of diet.
Interestingly, using another obesity mouse model, leptin-
deficient (ob/ob) mice, we also observed a significant decreased of
MAIT cell frequency in both ileum and Epi-AT when compared
with (ob/+) littermate controls (Supplementary Fig. 3a, e).
Decreased frequency and number of MAIT cells in Epi-AT and
ileum of obese mice could result from impaired recruitment and
proliferation, and increased cell death. To analyze MAIT cell
migration, CD45.1+MAIT cells were injected into lean and obese
B6 mice and analyzed in Epi-AT and ileum 5 days later
(Supplementary Fig. 1b). Similar frequency of CD45.1+ MAIT-
cells, among αβT lymphocytes as well as among CD45+ cells, was
observed in both lean and obese B6 mice (Fig. 1e). Analysis of
MAIT cell proliferation based on Ki67 staining did not reveal any
difference between MAIT cells from obese and lean mice (Fig. 1f;
Supplementary Fig. 1c). In contrast, analysis of the expression of
anti- and pro-apoptotic molecules in MAIT cells suggested
increased apoptosis of MAIT cells from obese mice compared
with lean mice. Transcript level of pro-apoptotic molecules such
as cMyc, Casp9 and Bax were increased, whereas the level of Bcl-2
mRNA was decreased in MAIT cells during obesity (Fig. 1g).
Difference in BCL-2 expression in the ileum and Epi-AT was
confirmed at the protein level, and no such difference was
observed in the spleen, liver, and colon (Fig. 1h; Supplementary
Fig. 1d). Altogether these data suggest that MAIT cells in Epi-AT
and ileum of obese mice are undergoing apoptosis leading to
lower frequency.
MAIT cells exhibit an inflammatory profile. Next, we analyzed
the phenotype and cytokine production by MAIT cells from
different tissues of mice fed ND or HFD. The expression of the
maturation/effector marker CD44 was significantly increased on
the surface of MAIT cells from Epi-AT and ileum of mice fed
HFD compared with mice under ND (Fig. 2a, b). In parallel, a
CD69 activation/retention marker was significantly decreased in
both tissues from obese mice (Fig. 2a, b). Of note, there was no
modification of CD44 and CD69 expression on MAIT cells from
the spleen, and only slight modifications were seen in the liver
and colon (Supplementary Fig. 2a, b).
Cytokine production analyses by qPCR and flow cytometry
showed that ileum MAIT cells produced more IL-17A, and Epi-
AT MAIT cells produced more TNF-α and IL-17A in obese mice
(Fig. 2c; Supplementary Fig. 2c–e). Increased cytokine produc-
tion was also observed in MAIT cells from the liver, but not
colon (Supplementary Fig. 2f). Analysis of cytokine and
chemokine receptor transcripts, usually associated with Th1
response (IL-18R) and Th17 response (CCR6), in MAIT cells
from obese compared with lean mice showed overexpression of
these receptors by MAIT cells isolated from ileum and Epi-AT,
respectively (Supplementary Fig. 2c). According to overexpres-
sion of Il18r mRNA by MAIT cells from the ileum of obese mice,
immunofluorescence staining showed an increased expression of
T-bet, a key transcription factor of Th1 cytokines42 (Supple-
mentary Fig. 2g, h). Together these data show that MAIT cells
are activated and produce inflammatory cytokines in both Epi-
AT and ileum from obese mice.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17307-0
2 NATURE COMMUNICATIONS |         (2020) 11:3755  | https://doi.org/10.1038/s41467-020-17307-0 | www.nature.com/naturecommunications
In ob/ob mice, similarly as in HFD-fed mice, there was an
increased expression of CD44 on MAIT cells from Epi-AT, and a
decreased expression of CD69 on MAIT cells from both ileum and
Epi-AT when compared with (ob/+) littermate controls (Supple-
mentary Fig. 3b, c, f, g). Moreover, a higher frequency of MAIT cells
from the ileum and Epi-AT produced pro-inflammatory cytokines
(IL-17A in ileum, TNF and IL-17A in Epi-AT) (Supplementary
Fig. 3d, h).
Next, we investigated whether MAIT cell activation was
associated with increased abundance of MAIT cell ligand
produced by gut microbiota from obese mice. Using two
bioassays, we assessed the ability of gut microbiota from lean
and obese mice to activate MAIT cells (Fig. 2d; Supplementary
Fig. 4a, b). There was a decreased activation of MAIT cells with
cecum microbiota from obese mice compared with those from
lean mice. Of note, this activation was MR1-specific, as it was
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inhibited in presence of non-activating ligand acetyl-6-
formylpterin (Ac-6-FP)43,44 or blocking MR1 antibody45. To
determine whether microbial community gene content contri-
butes to lower level of MAIT cell agonist ligand upon HFD, we
performed random shotgun sequencing of cecal microbial DNA
from ND- or HFD-fed mice. The Kyoto Encyclopedia of Genes
and Genomes (KEGG) orthology analysis showed that the
riboflavin biosynthesis pathway was significantly downregulated
in samples from HFD compared with ND-fed mice (Supplemen-
tary Fig. 4c). More precisely ribBA, ribD, ribH, and ribE genes
were less abundant, whereas ribB gene was more abundant in
microbiota from HFD-fed mice, and these differences could lead
to decrease synthesis of MAIT cell agonist ligands (Fig. 2e, f;
Supplementary Fig. 4d). Together bioassay and metagenomic data
suggest that local activation of MAIT cells is not due to elevated
presence of activating ligands, but rather to the pro-inflammatory
milieu of Epi-AT and ileum of obese mice.
MAIT cells promote metabolism dysfunction during obesity.
To determine the role of MAIT cells in the pathogenesis of T2D
and obesity, we analyzed MR1−/− B6 mice that lack MAIT cells,
since the MR1 molecule is required for thymic development of
MAIT cells29,46–48. Conversely, Vα19+/− transgenic B6 mice that
exhibit a tenfold increased frequency of MAIT cells were also
analyzed (Supplementary Fig. 5a). To induce obesity, these mice
and their respective littermates controls, MR1+/− and Vα19−/−
mice were fed with HFD for 12 weeks. We first investigated
glucose homeostasis in MR1−/− and Vα19+/− mice and per-
formed insulin tolerance test (ITT) and oral glucose tolerance test
(OGTT) after 12–16 weeks of HFD (Fig. 3a). Vα19+/− mice had
decreased insulin sensitivity than their littermate controls,
whereas MR1−/− mice presented an enhanced insulin tolerance
when compared with their littermate controls. Similarly, while
Vα19+/− mice were more glucose intolerant, MR1−/− mice had
improved glucose tolerance. Glucose metabolism dysfunction was
not due to impaired insulin secretion (Fig. 3b). The impact of
MAIT cells on insulin resistance was confirmed at the tissue level
by analysis of Akt phosphorylation, which is a readout of intra-
cellular insulin signaling (Fig. 3c; Supplementary Fig. 5b, c).
Relative amount of phosphorylated Akt in Epi-AT was increased
in MR1−/− mice and reduced in Vα19+/− mice compared with
their littermate controls, and similar data were observed in the
liver and muscle from Vα19+/− mice. In both fasted and fed
MR1−/− mice, basal blood glucose level was significantly
decreased when compared with control littermates (Supplemen-
tary Fig. 5d). Conversely, in fasted and fed Vα19+/− mice, basal
blood glucose level was significantly increased. Moreover, basal
serum insulin concentration and homeostatic model assessment
of insulin resistance (HOMA-IR) index were decreased in
MR1−/− mice and increased in Vα19+/− mice, under HFD
(Fig. 3d; Supplementary Fig. 5e). Of note during the course of
high-fat feeding period, there was no difference in weight gain,
and at the end of the regime there was no differences in body
weight, percentage of lean or fat mass and Epi-AT weight in both
Vα19+/− and MR1−/− mice compared with their littermate
controls (Supplementary Fig. 6a–e). No differences were observed
regarding food intake, respiratory exchange ratio (RER)
(Supplementary Fig. 6f, g). However, histology analysis showed
that under HFD adipocyte size was increased in Epi-AT of
Vα19+/− mice compared with their littermate controls. Inversely,
under HFD, adipocyte size in Epi-AT was smaller in MR1−/−
mice than in littermate controls (Fig. 3e; Supplementary Fig. 6h).
To further evaluate the impact of MAIT cells on Epi-AT
function, expression of two key adipokines49, adiponectin and
leptin, was measured by qPCR (Fig. 3f). Adiponectin expression
was decreased, whereas leptin expression was increased in
Vα19+/− mice compared with their littermate controls. Opposite
results were obtained in MR1−/− mice. These results indicate that
MAIT cells are involved in the deregulation of Epi-AT home-
ostasis. We next analyzed expression of two lipolytic enzymes,
adipose triglyceride lipase (Atgl) and hormone sensitive lipase
(Hsl), involved in intracellular degradation of triglycerides in
adipose tissue. Under HFD, while expression of both genes was
increased in Vα19+/− mice, compared with their control
littermates, in MR1−/− mice, expression of Atgl and Hsl (not
significantly) was decreased (Fig. 3f). According to increased
expression of these genes in Vα19+/− mice, there was an elevated
concentration of circulating glycerol and triglycerides in these
mice fed HFD, and conversely there was a lower level of these
lipids in the serum of MR1−/− mice fed HFD (Fig. 3g, h). The
expression of an adipogenic regulator, transcription factor
peroxisome proliferator-activated receptor gamma (Pparγ)50,51,
was significantly decreased in Epi-AT of Vα19+/− mice and
increased in Epi-AT of MR1−/− mice (Fig. 3f). Altogether these
data revealed the deleterious role of MAIT cells on glucose and
lipid metabolism.
MAIT cells exacerbate inflammation in adipose tissue. Since
MAIT cells from Epi-AT of obese B6 mice produced high level of
pro-inflammatory cytokines, we investigated whether MAIT cells
had a general impact on the inflammatory status of these tissues.
In Epi-AT, transcript level of cytokines known to be involved in
inflammation (Ccl2 , Ccl5 , Il1β, Il6 , Il17a, Ifnγ, and Tnfα) were
significantly increased in Vα19+/− mice compared with their
littermate controls, whereas in MR1−/− mice expression of these
genes was decreased (Fig. 4a). Opposite results were observed for
molecules associated with regulatory function in Epi-AT (Foxp3 ,
Il5 , and Il13 ). The inflammatory status of tissue was confirmed at
Fig. 1 MAIT cell alterations during obesity. a Representative dot plots of MAIT cell and control MR1-Tet staining. The numbers represent MAIT cells
frequency among αβT cells. bMAIT cell frequency among αβT lymphocytes in blood (ND n= 6; HFD n= 6), liver, colon, ileum (ND n= 5; HFD n= 6), Epi-
AT (ND n= 6; HFD n= 7), and spleen (n= 10 per group). c MAIT cell absolute numbers in the ileum (ND n= 8; HFD n= 10) and MAIT cell number per
gram of Epi-AT (ND n= 13; HFD n= 12). d MAIT cell frequency kinetic analysis of mice fed ND or HFD in the ileum (0 weeks n= 8; 6 weeks ND n= 11,
HFD n= 14; 12 weeks ND n= 9, HFD n= 10; 16 weeks ND n= 10, HFD n= 13) and Epi-AT (0 weeks n= 8; 6 weeks ND n= 11, HFD n= 14; 12 weeks ND
n= 15, HFD n= 15; 16 weeks ND n= 17, HFD n= 19). Pooled data from four independent experiments are represented. eMigration of MAIT cells into lean
or obese recipient mice after 12 weeks of ND or HFD. Purified MAIT cells from CD45.1 Vα19 transgenic Cα−/− mice were transferred into CD45.2 mice
and analyzed 5 days later. Graphs represent CD45.1 MAIT cells frequency in the ileum (n= 10 per group) and Epi-AT (n= 10 per group). Pooled data from
two independent experiments are represented. f Ki67 staining of MAIT cells from the ileum (ND n= 8; HFD n= 10) and Epi-AT (ND n= 10; HFD n= 10) of
12 weeks HFD or ND-fed mice. Pooled data from two independent experiments are represented. g qPCR analysis of apoptotic (cMyc, Caspase9, and Bax)
and anti-apoptotic (Bcl-2) gene expression by FACS-sorted MAIT cells from mice fed ND (n= 8) or HFD (n= 9) for 12 weeks. Pooled data from two
independent experiments are represented. h BCL-2 MFI in MAIT cells from the ileum and Epi-AT from mice fed ND or HFD for 12 weeks (n= 4 per group).
For b, c, e, and f, each symbol represents an individual mouse (small horizontal lines indicate the mean ± S.E.M.). In d, g, and h, data are represented as
mean ± S.E.M. Statistical analysis were performed by two-tailed Mann–Whitney test, *P < 0.05, **P < 0.01, ***P < 0.001 (see also Supplementary Fig. 1).
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the immune cell level and corroborated by the frequency of
conventional T cells expressing RORγt a key transcription factor
for IL-17 production52 (Supplementary Fig. 7a, b). Of note, under
ND only slight differences were observed in Vα19+/− mice
compared with their controls (Supplementary Fig. 7c).
Since MAIT cells played a key role in the inflammatory status
and function of Epi-AT during obesity, we investigated whether
MAIT cells influenced frequency of other immune cells in this
tissue from the different mouse lines fed ND or HFD
(Supplementary Figs. S8–S10). In agreement with Foxp3 mRNA
level in HFD-fed mice, there was a decreased frequency of
Foxp3+ Treg cells in Vα19+/− mice and an increased frequency
of Foxp3+ Treg cells in MR1−/−, compared with their respective
littermate controls (Fig. 4b; Supplementary Fig. 10a). Similar
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modification was observed for ILC2 and eosinophils, two other
regulatory immune cells in Epi-AT (Fig. 4b; Supplementary
Fig. 10b, c). In contrast, frequency of inflammatory cells
(conventional CD8+ T lymphocytes and NK cells) was increased
in obese Vα19+/− mice, whereas these cells were less frequent in
obese MR1−/− mice, compared with their respective littermate
controls (Fig. 4c; Supplementary Fig. 10d). As controls, analyses
of Epi-AT from WT B6 mice under ND and HFD confirmed
previous studies8,10,12 showing decreased frequency of Treg cells,
ILC2, and eosinophils and increased frequency of conventional
CD8+ T cells and NK cells. While macrophage frequency from
the different mouse lines under HFD was similar, MAIT cells had
an impact on macrophage subsets (Fig. 4d–h; Supplementary
Fig. 10e, f). There was a lower frequency of CD206+CD11c− M2
and a higher frequency of CD206−CD11c+ M1 macrophages in
obese Vα19+/− mice, compared with their littermate controls.
Opposite results were observed in MR1−/− mice compared with
their littermates (Fig. 4e, f). Phenotype of M1 and M2
macrophages were corroborated by their cytokine profiles
(Fig. 4g). Kinetics analysis of immune cells in Vα19+/− and
MR1−/− mice revealed that MAIT cells impact macrophage
phenotype as early as 6 weeks of HFD, whereas changes in other
immune cell populations were mainly observed at 12 weeks of
HFD (Fig. 4h; Supplementary Fig. 10a–d). Taken together, these
analyses of immune cell populations in Epi-AT strengthened the
pro-inflammatory role of MAIT cells in obesity.
Inflammatory crosstalk between MAIT cells and macrophages.
Since macrophages represent the more abundant immune cell
population in Epi-AT53,54 and that MAIT cells impacted their
phenotype, we further investigated in vitro MAIT cell and mac-
rophage crosstalk. M0-macrophages differentiated from bone
marrow of B6 mice were cultured in presence of MAIT cells
either naive (nMAIT) or pre-activated with CD3 and CD28 mAbs
(acMAIT). Interestingly, acMAIT cells promoted differentiation
of M0 into M1 macrophages, as indicated by their phenotype
(CD206−CD11c+) and expression of Il1β, Ccl2 , and Il10 (Fig. 5a;
Supplementary Fig. 11a, b). However, co-culturing acMAIT cells
with M0 generated from MR1−/− mice (MΦMR1−/−) had only a
moderate impact on their differentiation into M1 macrophages,
as illustrated by M1/M2 ratio (Fig. 5a). In contrast to major
requirement for MR1, blocking cytokines (IL-17, IFNγ, and
TNFα) had only a limited impact on macrophage polarization in
presence of acMAIT cells (Fig. 5b).
Next we analyzed reciprocal impact of macrophages on MAIT
cell phenotype and function after co-cultures of nMAIT cells with
M0, M1, or M2. Interestingly, M1 macrophages expressed higher
levels of Mr1/MR1 than M0 and M2 macrophages (Fig. 5c).
nMAIT cells cultured in presence of M1 macrophages expressed
lower level of CD69 and higher level of CD44, IL-17A, and TNFα,
as compared with cultures with M0 or M2 macrophages (Fig. 5d).
These phenotype and cytokine profile recapitulate those observed
in Epi-AT of obese mice. To assess the role of TCR–MR1
interaction in MAIT cell activation by macrophages, agonist and/
or inhibitory ligands were added to cultures. Addition of 5-(2-
oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU) ago-
nist33,43 induced IL-17A and IFN-γ production that was inhibited
in presence of Ac-6-FP43. In contrast, TNFα production was
independent of TCR triggering. Requirement for TCR–MR1
interaction for IL-17A and IFN-γ production was confirmed in
co-cultures with MR1-deficient macrophages (Fig. 5e). Together
these data demonstrated that MAIT cell and M1 macrophage
crosstalk promotes their inflammatory function.
MAIT cells induce gut alteration and dysbiosis. Similarly, as in
Epi-AT, obesity induced major changes on MAIT cell frequency,
phenotype, and cytokine production in ileum. Therefore, we
investigated whether MAIT cells had impact in ileum inflam-
mation and function. As in Epi-AT, MAIT cells promote
inflammation in the ileum of Vα19+/−mice on HFD, whereas the
ileum of obese MR1−/− mice was less inflamed (Fig. 6a). This
observation was confirmed at immune cell transcript level and
corroborated by frequency of Treg cells, ILC2, ILC3, and con-
ventional αβT cells expressing RORγt (Fig. 6b, c; Supplementary
Fig. 12a–e). In ND conditions, only small differences were
observed in Vα19+/− mice (Supplementary Fig. 12c).
To assess whether inflammatory status induced by MAIT cells
during obesity had an impact on gut integrity, we analyzed FITC-
dextran translocation to blood after oral gavage of HFD-fed Vα19
+/− and MR1−/− mice and their respective controls (Fig. 6d).
MAIT cells aggravated gut leakiness since translocation of FITC-
dextran was increased in Vα19+/− mice and reduced in MR1−/−
mice. In agreement with these data, there was higher mRNA level
of tight junction proteins such as zonulin-1, claudin-4 and
occludin, and of mucin, major component of mucus layer, in
epithelial cells from ileum of HFD-fed MR1−/− mice and
opposite results in HFD-fed Vα19+/− mice (Fig. 6e). Since
MAIT cells increased gut inflammation and leakiness in obese
mice, we investigated whether MAIT cells had also an impact on
gut microbiota composition. 16S-rRNA sequencing was per-
formed on feces to evaluate relative abundance of different
bacterial phyla in various mouse lines (Supplementary Table 1).
Upon HFD, there was a significant increase of Actinobacteria
phylum (Fig. 6f), Coriobacteriaceae family, and 11 bacterial OTU
clusters assigned to this family (Fig. 6g, h; Supplementary
Fig. 13a, c) in Vα19+/− mice compared with their littermate
controls. In HFD-fed MR1−/− mice, there was a significant
Fig. 2 MAIT cell phenotype and function during obesity. a, b MAIT cell frequency kinetic analysis of B6 mice fed ND or HFD for 3, 6, and 12 weeks.
a Graphs representing CD44 mean fluorescence intensity (MFI) (3 weeks ND n= 5, HFD= 6; 6 weeks ND n= 8, HFD n= 9; 12 weeks ND n= 9, HFD
n= 11) and percentage of CD69+MAIT cells (3 weeks ND n= 8, HFD= 9; 6 weeks ND n= 7, HFD n= 11; 12 weeks ND n= 8, HFD n= 9) among the total
MAIT cells from the ileum. Pooled data from three independent experiments are represented. b Graphs representing CD44 mean fluorescence intensity
(MFI) (3 weeks ND n= 5, HFD= 6; 6 weeks ND n= 9, HFD n= 12; 12 weeks ND n= 7, HFD n= 8) and percentage of CD69+ MAIT cells 3 weeks ND
n= 10, HFD= 10; 6 weeks ND n= 9, HFD n= 12; 12 weeks ND n= 8, HFD n= 10) among total MAIT cells from Epi-AT. Pooled data from three
independent experiments are represented. Representative histograms of staining on MAIT cells from the ileum and Epi-AT. c Intracellular staining of
MAIT cells for TNFα, IFN-γ, and IL-17A. Frequency of positive MAIT cells from the ileum and Epi-AT of lean (n= 8) and obese (n= 9) mice are indicated.
Pooled data from three independent experiments are represented. d Analysis of the abundance of MAIT cell-activating ligands using a bioassay based on
the activation of purified MAIT cells by fecal supernatants from the cecum of HFD-fed (n= 14) mice or ND-fed (n= 15) mice in the presence of Ac-6-FP
when indicated. Pooled data from four experiments are represented. e Heatmap representing microbial gene level abundance of key riboflavin biosynthesis
enzymes from ND-fed mice and 12 weeks HFD-fed mice (n= 20 for per group). f The Riboflavin biosynthesis pathway in green decreased enzyme gene
expression, and in red, increased enzyme gene expression. For a–d, each symbol represents an individual mouse (small horizontal lines indicate the mean ±
S.E.M.). Statistical analysis was performed by two-tailed Mann–Whitney test, *P < 0.05, **P < 0.01, ***P < 0.001 (see also Supplementary Figs. 2–4).
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decrease of Actinobacteria phylum when compared with their
littermate controls, whereas other phyla (Bacteroidetes, Firmi-
cutes, Protobacteria, and Deferribacteres) remained unchanged
(Fig. 6i; Supplementary Fig. 13b). In agreement, Coribacteriaceae
family (Actinobacteria phylum) and Olsenella genus (a member
of Coribacteriaceae family) decreased in MR1−/− mice when
compared with their littermates (Fig. 6j; Supplementary Fig. 13c).
Conversely, an increase of Clostridiaceae (belonging to Firmicutes
phylum) existed in MR1−/− mice compared with their control
group (Fig. 6k). Consistently at the genus level, Clostridium sensu
stricto and two Lachnospiraceae groups also increased while
Eubacterium rectale group displayed lower abundance in MR1−/−
mice than in control littermates (Fig. 6k), and three OTU clusters
(556, 21, and 451) assigned to Lachnospiraceae varied between the
two mice groups (Fig. 6l; Supplementary Fig. 13c). We also
investigated whether changes in microbiota composition observed
in HFD-fed Vα19+/− and MR1−/− mice impacted MAIT cell
ligands, using bioassay. MAIT cells were less activated with
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cecum microbiota from Vα19+/− mice when compared to their
littermate controls. Conversely cecum microbiota from MR1−/−
mice increased MAIT cell activation when compared to their
littermate controls (Supplementary Fig. 13d). Together these
results showed that during obesity MAIT cells aggravate gut
microbiota dysbiosis.
Dysbiosis induced by MAIT cells impact ileum function. To
determine whether gut microbiota differences induced by
MAIT cells play a role in metabolism dysfunction, microbiota
transfer experiments were performed. Feces from HFD-fed
Vα19+/− mice, MR1−/− mice, or their littermate controls were
transferred into B6 recipient mice (Fig. 7a). 16S-rRNA sequen-
cing analysis showed efficacy of gut microbiota transfer
(Fig. 7b–d, Supplementary Fig. 14a, b). Bifidobacteriaceae (Acti-
nobacteria phylum) and Lactobacillaceae (Firmicutes phylum)
families were significantly lower in B6 mice transplanted with
Vα19+/− than littermate microbiota (Fig. 7c) and analysis at
OTU level confirmed a differential distribution between various
groups of recipient mice (Fig. 7d). Regarding gut mucosa func-
tion, as observed in donor mice, recipient B6 mice that had
received feces from HFD-fed Vα19+/− or MR1−/−mice exhibited
increased or decreased intestinal permeability, respectively, as
compared with recipient B6 mice transferred with gut microbiota
from their littermate controls (Fig. 7e). These modifications of gut
permeability in recipient mice were associated with marked
changes in Treg cell frequency in the ileum of mice transferred
with feces from Vα19 and MR1−/− mice and to increased ILC2
and ILC3 frequency in ileum from mice transferred with
microbiota from MR1−/− donors (Fig. 7f). These immune cell
compositions were similar to the one observed in donor mice
under HFD (Fig. 6b; Supplementary Fig. 12d). In contrast, gut
microbiota transfer had only a moderate impact on Epi-AT
immune cell populations (Fig. 7g). These data showed that during
obesity, MAIT cells promote gut microbiota dysbiosis thereby
increasing gut permeability, which is not sufficient to exacerbate
metabolic dysfunction.
M1-macrophage polarization is independent of microbiota.
The role of microbiota was also evaluated by co-housing Vα19+/−
and MR1−/− mice with their respective littermates for 12 weeks
under HFD and metabolic tests (OGTT and ITT) were per-
formed. Co-housing abolished metabolic differences previously
observed when mice were bred in separate cages (Supplementary
Fig. 14c, d). Analysis of immune cells showed that Foxp3+ Treg
and ILC3 cell frequency was similar in the ileum of Vα19+/− and
MR1−/− mice co-housed with their respective littermate controls
(Fig. 7h). However, eosinophils, M2 and M1-macrophages fre-
quencies remained significantly different in Epi-AT of Vα19+/−
and MR1−/− mice when compared with their littermate controls
(Fig. 7i, j). Gene expression analyses of macrophages corrobo-
rated flow-cytometry data (Fig. 7k). Together these results high-
light the direct pro-inflammatory role of MAIT cells in Epi-AT,
independently from gut microbiota dysbiosis.
MAIT cell TCR-blocking ligand improves metabolic para-
meters. Since MAIT cell and macrophage crosstalk involved
TCR–MR1 interaction, we performed in vivo treatment with the
inhibitory ligand Ac-6-FP to assess whether it could improve
metabolic parameters. Obese mice (B6 WT and Vα19+/−) were
treated for 8 weeks, and such treatment ameliorated insulin
sensitivity and glucose tolerance as compared with untreated mice
(Fig. 8a, b). Of note, Ac-6-FP treatment of obese MR1−/− mice
did not have any effect on their glucose tolerance or insulin
sensitivity (Supplementary Fig. 15a). Blocking MAIT cell activa-
tion decreased inflammation in the ileum (Il17) and Epi-AT
(Ccl2 , Il1β, Il6 , and Il17) and improved Epi-AT function (Atgl and
Hsl enzymes) mimicking Epi-AT status in MR1−/− mice (Fig. 8c,
d). Ac-6-FP treatment had no effect on MAIT cell frequency and
their CD44 expression in both tissues, whereas it increased CD69
MAIT cell expression in Epi-AT (Fig. 8e–g; Supplementary
Fig. 15b, c). Interestingly, MAIT cell production of IL-17A was
significantly decreased in the ileum and Epi-AT of Ac-6-FP-
treated mice (Fig. 8h), and M1/M2 ratio was decreased in Epi-AT
(Fig. 8i, j; Supplementary Fig. 15d, e). Finally, Ac-6-FP treatment
also impacted gut microbiota composition, as it significantly
decreased Actinobaceria and increased Bacteroïdetes abundance
(Fig. 8k). All these data suggest that blocking MAIT cell activa-
tion during obesity could be an efficient strategy to lower chronic
inflammation, prevent dysbiosis, and improve metabolic
parameters.
Discussion
This study shows that obesity has an impact on MAIT cell fre-
quency and function in Epi-AT and ileum and conversely
MAIT cells promote chronic inflammation and gut dysbiosis,
which together induced lipid and glucose metabolism deregula-
tion (Supplementary Fig. 16). In obese mice, MAIT cell frequency
and number decreased specifically in blood, ileum, and Epi-AT.
These results in mouse models corroborated previous results in
obese and/or T2D patients showing decreased blood MAIT cell
frequency and number as well as decreased MAIT cell frequency
in adipose tissue35–37. MAIT cells overexpressed pro-apoptotic
genes (Bax, cMyc, and Casp9 ) and downregulated the anti-
Fig. 4 MAIT cells impact other immune cell populations in Epi-AT of obese mice and induce inflammation. a Graph showing the relative quantity of pro-
and anti-inflammatory cytokine transcripts in Epi-AT of Vα19+/− and MR1−/− mice and their littermate controls fed with HFD during 12 weeks (n= 6 mice
per group). b–d Graphs showing the frequency of Foxp3+ Treg cells, ILC2, eosinophils (b), CD8 αβT cells, NK cells (c), and macrophages (d) among
CD45+ cells in the Epi-AT stroma-vascular fraction (SVF) of B6 mice fed with ND (n= 10) or HFD (n= 10), and Vα19+/− (ND n= 12, HFD n= 13) and
MR1−/− (ND n= 10, HFD n= 16) mice and their respective littermate controls (Vα19−/− (ND n= 12, HFD n= 11) and MR1+/− (ND n= 12, HFD n= 17))
after 12–16 weeks of HFD or ND feeding. Pooled data from two to four experiments are represented. e Representative dot plot of Epi-AT macrophages sub-
populations in Vα19+/− and MR1−/−mice and their respective littermate controls after 12–16 weeks of HFD or ND feeding. Data show the frequency of M2
(CD206+CD11c) and M1 (CD206−CD11c+) among CD11b+F4/80+ total macrophages. f M1 (CD206−CD11c+) and M2 (CD206+CD11c+) ratio in the
Epi-AT of Vα19+/− (n= 5), MR1−/− (n= 6) and their littermate controls (Vα19−/− n= 5 and MR1+/− n= 6). g Graphs showing the relative quantity of
pro-inflammatory M1 markers (Ccr2, Mcp1, Il1β, Il6, and Tnfα) and anti-inflammatory M2 markers (Tgfbr2, Cd206, Cd163, and Il10) transcripts in Epi-AT
macrophages from Vα19+/− (n= 10) and MR1−/− (n= 14) mice and their respective littermate controls (Vα19−/− n= 13 and MR1+/− n= 16) fed on HFD
during 12 weeks. h Kinetic analysis of M2 macrophages and M1-macrophages frequency of Vα19+/− and MR1−/− mice and their respective littermate
controls fed with ND or HFD during 3, 6, and 12 weeks (n= 6 per group for each time point). In a, e, and h, all data are represented as mean ± S.E.M. For
b–d and g, each symbol represents an individual mouse (small horizontal lines indicate the mean ± S.E.M.). All statistical analyses were performed by two-
tailed Mann–Whitney test. *P < 0.05, **P < 0.01, ***P < 0.001 (see also Supplementary Figs. 7, 8, 9 and 10).
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apoptotic Bcl-2/BCL-2 gene and protein in Epi-AT and ileum of
obese mice compared with lean controls. Our previous data in
humans showed that co-culture of MAIT cells with visceral adi-
pose tissues from obese patients induced the downregulation of
BCL-236. Together these observations in humans and mice
suggest that obesity chronic inflammation in VAT and ileum
could promote MAIT cell apoptosis. Even though we have
recently proposed that hyperglycemia could induce MAIT cell
apoptosis55, since MAIT cell frequency is mainly reduced in
adipose tissue and ileum, we favor the role of local inflammation.
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Indeed, in many inflammatory and autoimmune diseases,
MAIT cells are activated and prone to activation-induced cell
death by apoptosis20,56,57.
Another striking observation regarding MAIT cells in obesity is
their inflammatory status and their propensity to promote
inflammation in adipose tissue and ileum. In these tissues,
MAIT cells upregulated expression of several molecules involved
in inflammation, such as transcription factor (T-bet), chemokine/
cytokine receptors (CCR6, IL-18R), and cytokines (TNFα and
IL-17). Human studies also show overexpression of IL-17 by
MAIT cells from adipose tissue of obese patients35,36. Studies of
mouse models with high frequency of MAIT cells or MAIT cell
deficiency demonstrate the role of these cells in inflammation of
both adipose tissue and ileum. This was evidenced by gene
expression analysis of whole tissues and purified total immune
cells, as well as by characterization of various immune cell
populations by flow cytometry. Kinetic analysis revealed that the
impact of MAIT cells on adipose tissue eosinophils and macro-
phage phenotype could be observed after 6 weeks of HFD, before
detectable alteration of glucose metabolism. However at 12 weeks
of HFD, enhanced inflammation induced by MAIT cells was
associated with exacerbated metabolic dysfunction in adipose
tissue. In vitro mechanistic studies highlighted a bidirectional
crosstalk between macrophages and MAIT cells. M1 macrophages
activated IL-17 production by MAIT cells, in a MR1-dependent
manner and even in absence of exogenous ligand. Conversely,
activated MAIT cells favored differentiation of M1 macrophages.
While such macrophage–MAIT cell crosstalk was also observed
in vivo, it is not clear whether one of both cell types act as an
initiator during obesity since we did not detect alteration of both
cell types at 3 weeks of HFD. In vitro experiments demonstrated
the role of TCR–MR1 recognition for IL-17 production by
MAIT cells in presence of macrophages, whereas TNFα produc-
tion was MR1-independent. The key role of MR1–TCR interac-
tion in inflammation and metabolism dysregulation induced by
MAIT cells was further evidenced by in vivo treatment with
antagonist ligand (Ac-6-FP) blocking MR1 recognition by
MAIT cells. These results highlighting the role of TCR–MR1
interaction in MAIT cell function is reminiscent of our recent
studies showing MAIT cell activation of myofibroblast in the
context of liver fibrosis58.
In parallel to the impact on tissue inflammation during obesity,
MAIT cells also induced gut microbiota alteration. This was
shown by bacteria 16S-rRNA sequencing, metagenomic as well as
by two bioassays evaluating MAIT cell ligands abundance. There
was an opposite effect on Actinobacteria abundance in MR1−/−
and Vα19+/− mice compared with their control groups indicative
of MAIT cell effect on gut microbiota composition. This impact
of MAIT cells on Actinobacteria was confirmed by Ac-6-FP
treatment. Of note, Coriobacteriaceae, which are altered accord-
ing to MAIT cell status, have been associated to metabolic dis-
eases and host lipid metabolism59. Other modifications of
microbiota observed at family, order, genus, and OTU levels
presented a strong coherence, and targeted microorganisms have
already been associated to metabolic diseases and
immunomodulation60–62. Gut microbiota alteration could be
related to increased ileum inflammation. Gut microbiota transfer
from HFD-fed mice harboring high frequency of MAIT cells
induced ileum inflammation and gut mucosa dysfunction in
recipient mice. Moreover, co-housing abolished difference in
ileum inflammatory status of mice expressing various frequencies
of MAIT cells. Together these data strengthened the role of gut
microbiota in ileum inflammation induced by MAIT cells during
obesity. Ileum inflammation is associated with loss of gut integ-
rity that can promote endotoxemia, which favors systemic insulin
resistance and T2D63,64.
Interestingly, our study reveals a decreased production of
MAIT cell-activating ligand in gut microbiota from HFD mice.
This was suggested by MAIT cell activation in bioassays and
confirmed by gene abundance of enzymes (RibBA, RibD, and
RibE) necessary for the biosynthesis of MAIT cell agonist
ligands33,65. Only RibB gene leading to consumption of MAIT cell
ligand precursor was more abundant upon HFD. Our data are
reminiscent to metagenomic analyses in obese/T2D patients and
mouse models showing impaired riboflavin synthesis in feces
microbiota27,66. Therefore decreased abundance of MAIT cell
agonist ligand could play a role in MAIT cell behavior during
obesity. It is possible that lower activation ability of gut micro-
biota from obese mice might contribute to MAIT cell apoptosis in
the ileum and Epi-AT, in addition to other local factors produced
by these inflamed tissues. Decreased bacterial-derived agonist
ligand availability might represent a way to dampen MAIT cell
activation in inflammatory conditions, since our data showed that
MAIT cell activation in vitro and in vivo in the context of obesity
is MR1-dependant.
This study in obesity revealed the deleterious role of
MAIT cells in promoting ileum inflammation, gut mucosa dys-
function, and gut microbiota alteration, whereas we had pre-
viously shown in mouse models of T1D that MAIT cells were
protective by maintaining gut integrity56. This discrepancy
prompts further analysis of intestinal MAIT cells in both
pathologies to particularly determine their production of effector
Fig. 5 MAIT cells and macrophages crosstalk induces an inflammatory response in vitro. a, b Wild-type (clear background) or MR1−/− (gray
background) M0 macrophages were co-cultured for 72 h with spleen MAIT cells, either naive (nMAIT) or pre-activated (acMAIT). a Data showing the
frequency of M1 macrophages (CD206-CD11c+) and M2 macrophages (CD206+CD11c−) among CD11b+F4/80+ total macrophages and M1/M2 ratio
(n= 12 samples over two independent experiments). b Wild-type or MR1−/− M0 macrophages were co-cultured for 72 h with spleen pre-activated
MAIT cells (acMAIT) in presence of cytokine-neutralizing antibodies (anti-IL-17, anti-IFNγ, and/or anti-TNF). Data show the frequency of M1 macrophages
(CD206−CD11c+) and M2 macrophages (CD206+CD11c−) among CD11b+F4/80+ total macrophages and M1/M2 ratio (n= 8 samples over two
independent experiments). c Relative expression of Mr1 in M0, M2, or M1 macrophages and surface staining for MR1 in in vitro-differentiated
macrophages. Culture media contained 100 μM of Ac-6-FP. d–e Spleen nMAIT cells were co-cultured with M0-, M2-, or M1-differentiated macrophages
for 48 h in presence of 5-OP-RU agonist molecule. c Data showing the frequency of M1 macrophages (CD206−CD11c+) and M2 macrophages (CD206
+CD11c−) among CD11b+F4/80+ total macrophages co-cultured with acMAIT cells in medium with or without anti-IL-17A, anti-IFNγ and/or anti-TNFα
neutralizing antibodies (n= 4 samples). d CD44 and CD69 surface marker expression on nMAIT cells and intracellular staining of nMAIT cells for TNFα,
IFNγ, and IL-17A (n= 20 samples from four independent experiments). e Intracellular staining of MAIT cells co-cultured either with WT M0, M2, or M1
macrophages (round symbol, clear background) or MR1−/−M0, M2, or M1 macrophages (diamond symbol, gray background) for TNF-α, IFN-γ, and IL-17A
(n= 7 samples). Data are representative of at least three independent experiments. For a and a–e, each symbol represents an individual mouse (small
horizontal lines indicate the mean ± S.E.M.). In b, in M1/M2 ratio graph, $ symbol represents statistics between WT macrophages vs. MR1−/−
macrophages cultured in the same conditions. All statistical analyses were performed by two-tailed Mann–Whitney test. *P < 0.05, **P < 0.01, ***P < 0.001
(see also Supplementary Fig. 11).
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molecules that could impact other immune cells, epithelial cells,
as well as gut microbiota composition. Recent studies have
described an ambivalent role of MAIT cells20,67,68.
In summary, our data in mouse models of obesity not only
strengthened our previous results showing MAIT cell alterations
in blood and VAT from obese patients but also it revealed the
mechanisms by which MAIT cells contribute to metabolic dys-
function. Mouse models, which allowed analysis of several tissues,
revealed the pro-inflammatory profile of MAIT cells in both
adipose tissue and ileum that is associated with gut microbiota
and mucosa alteration. MAIT cells induced sustained adipose
tissue inflammation and gut microbiota dysbiosis that are both
required to induce insulin resistance and metabolic dysfunctions.
Moreover, this study might open therapeutic strategies based on
MAIT cell triggering to prevent insulin resistance and T2D.
Methods
Mice. All the mice used in this study were on C57BL/6J (B6) background. Vα19+/−
transgenic mice that contain a high frequency of MAIT cells (Vα19 Tg) and
Vα19−/− littermates controls, MR1−/− mice lacking MAIT cells and their MR1+/−
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littermate controls, Vα19+/− Cα−/− B6 mice for transfer experiments. These mice
have been previously described69. To better analyze MAIT cell phenotype, mouse
lines were backcrossed with Rorc(γt)-GFP Tg C57BL/6J mice70. Leptin-deficient
(ob/ob) males were purchased from Charles River at 11 weeks of age, and fed
regular chow diet ad libitum until sacrifice.
All mice used in the studies were males, and in all experiments mice of different
genotypes were separated at weaning, except when mentioned co-housing. At
8 weeks of age, mice from the different mouse lines (n= 5–7 per experiment) were
fed with a 60 kJ% fat diet (SSNIFF ref# E15742-347) or with a 10% fat diet (ND)
(SAFE, ref# A03 SP10) for 12 weeks. All animal experiments were approved by the
ethical committee CEEA34 (APAFIS # 4838-2015111715473538) and conducted in
accordance with the guidelines stated in the International Guiding Principles for
Biomedical Research Involving Animals, developed by the Council for
International Organizations of Medical Sciences (CIOMS). All mouse strains were
bred and maintained in under specific pathogen-free conditions in the mouse
facility of Cochin Institute, and at the “Centre exploration fonctionnelle (CEF)” at
Paris Sorbonne University.
Cell preparations. The fat pad adipose tissue was isolated from mice and digested
with 5–10 mL of collagenase H solution (1 mg/mL, Roche ref# 11074059001) at
37 °C for 30 min with shaking (150 rpm). After digestion, adipocytes were removed
by filtering through a 100-μm nylon mesh, and cell suspension was centrifuged for
5 min at 300 g to pellet the stroma-vascular fraction (SVF). SVF was washed with
FACS buffer containing 5% fetal calf serum (FCS, Dominique Dutscher, S1810-
500) and 0.1% sodium azide in PBS. Macrophages were directly analyzed from
SVF, whereas other immune cells were further enriched on Percoll density gra-
dients of 40 and 80% (GE Healthcare ref# 17–0891). The interface between the
layers was collected and suspended in PBS containing 5% FCS and 0.1% sodium
azide, to retrieve immune cells. After removal of fat tissue, feces and Payer’s pat-
ches, the intestine was extensively rinsed with HBSS without Ca2+ and Mg2+
containing 10 mM HEPES. Lamina propria cells were isolated using Lamina Pro-
pria Dissociation Kit (Miltenyi, 130-097-410) according to the manufacturer’s
instructions, and the cells suspension were enriched by Percoll as for adipose tissue.
Liver was perfused with RPMI 1640 medium (Gibco, 6187-010) supplemented with
5% FCS to remove circulating blood cells and then harvested. Liver was passed
through 70-μm mesh, and cells suspension was collected after 2 min centrifugation
at 48 g to avoid parenchymal cells. The supernatant was centrifuge again at 440 g,
and the pellet was then resuspended in 40% Percoll layered onto 80% Percoll and
centrifuged for 15 min at 780 g at room temperature. The immune cell fraction was
collected at the interface and suspended in PBS containing 5% FCS and 0.1%
sodium azide, to retrieve immune cells.
Flow cytometry. Cell suspensions prepared from various tissues were stained at
4 °C in PBS containing 5% FCS and 0.1% sodium azide. Surface staining was
performed with the following antibodies: anti-CD45 (30-F11), anti-TCRβ (H57),
and anti-CD103 (M290) mAbs from BD Biosciences; anti-CD45 (30-F11), anti-
CD8α (53-6.7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD11c (N418), anti-
CD206 (C068L2), anti-Sca-1 (D7), anti-NK1.1 (PK136), anti-CD19 (6D5), anti-
CD4 (GK1.5), anti-CD11b (M1/70), anti-CD127 (A7R34), anti-CD25 (PC61), and
anti-CD69 (HI-2F3) mAbs from Biolegend; anti-CD8α (53-6.7), anti-CD44 (IM7),
anti-Siglec-F (1RNM44N), anti-TCRγδ (GL-3), and anti-F4/80 (BM8) mAbs from
eBioscience.
Alpha-galactosylceramide-CD1d tetramer was prepared by the laboratory and
coupled to streptavidin-BV421 (Biolegend). Biotinylated mouse MR1 tetramers
loaded with the active ligand (5-OP-RU) were used to specifically identify
MAIT cells; biotinylated MR1 tetramers loaded with the non-activating ligand
acetyl-6-formylpterin (Ac-6-FP) were used as a negative control. MR1 tetramers
were generated by A.C. and J.M. and the NIH facility. MR1 tetramers were coupled
to streptavidin-PE (BD Bioscience). For intracellular staining, the cells were fixated
and permeabilized using the Foxp3 staining kit from eBioscience according to the
manufacturer’s instructions, cells were then stained with anti-Ki67 (SolA15),
anti–Foxp3 (FJK-16s), anti-Ror(γ)t (B2D) from eBioscience; anti-BCL-2 (BCL/
10C4), anti-PLZF (9E12 bioL), anti-T-bet (4B10) from Biolegend for 30 min at
4 °C. Intra-cytoplasmic staining for cytokine analysis were performed after PMA
(25 ng/ml) and ionomycin (1 μg/ml) stimulation for 4 h at 37 °C in presence of
Brefeldin A (10 μg/ml), all reagents from Sigma-Aldrich. After surface staining,
cells were fixed and permeabilized with Cytofix/Cytoperm kit (BD Biosciences),
washed, and incubated at 4 °C with antibodies to cytokines TNFα/ml), all reagents
from eBioscience; IFNγ (XMG1.2), IL-17A (TC11-18H10) from Becton Dickinson.
Data acquisition was performed using a BD Biosciences LSRFortessa cytometer,
and cell sorting was performed using BD Biosciences FACSAria III, then the results
were analyzed using FlowJo analysis software (Tree Star). Antibodies are listed in
Table 1.
MAIT cell transfer. MAIT cells were purified from Rorc(γt)-GFP Vα19 Tg Cα−/−
CD45.1 congenic B6 mice. These mice are highly enriched on MAIT cells. Cells
were isolated and purified from the spleen and mesenteric lymph nodes using
Dynabeads™ untouched™ mouse T cells kit according to the manufacturer’s
instructions. After purification, 5 million cells in 100 μl of PBS 2% FCS were
intravenously injected into CD45.2 B6 mice (lean or obese). Five days later, mice
were sacrificed, and CD45.1 MAIT cells were analyzed by flow cytometry.
RT-qPCR. RNA was extracted from tissues or purified cells using the RNeasy RNA
Mini and Micro Kit (Qiagen RNeasy Plus micro kit ref# 74034 and Qiagen RNeasy
mini Kit ref# 74104). Complementary DNAs were synthesized using Superscript III
reverse-transcriptase kit (Invitrogen ref# 18080-044). Quantitative PCR analysis
was performed with SYBR Green Master Mix (Roche ref# 001,04,352,887) using a
LightCycler 480 (Roche). 18S, Hprt, and Gapdh were used for normalization to
quantify relative mRNA expression levels. Relative changes in mRNA expression
were calculated using the comparative cycle method (2−ΔΔCt). Primers are listed in
Table 2.
Metabolic analysis. Glucose tolerance test: Oral glucose tolerance tests were
performed after 10–12 weeks of diet as follows: overnight fasted mice were injected
with glucose by gavage (2 g/kg body weight of glucose, 20% glucose solution;
G8270, Sigma). Blood glucose concentration was determined at 0, 15, 30, 60, and
90 min following the glucose load with a glucometer (Accu-Chek® Performa,
Roche) on blood from the tip of the tail vein. Insulin tolerance test: intraperitoneal
(i.p.) insulin tolerance tests were performed after 10–12 weeks of diet as follows:
6-h fasted mice were injected with 0.00075 U of insulin/g of mouse (0.075 U/mL in
PBS 1% BSA solution; Humalog 100 UI/mL, Lispro, Lilly). Blood glucose con-
centration was determined at 0, 10, 15, 30, 60, and 120 min following the glucose
load with a glucometer (Accu-Chek® Performa, Roche) on blood from the tip of the
tail vein. The area under the curve (AUC, 0-90 or 120 min) was calculated for each
group of mice.
Fig. 6 MAIT cells impact on ileum homeostasis and inflammation in obese mice. a Graph showing the relative quantity of cytokine transcripts in the
ileum of Vα19+/− and MR1−/−mice and their littermate controls fed with HFD during 12 weeks (n= 6 mice per group). b Graphs showing the frequency of
Foxp3+ Treg cells, among CD45+ cells in the ileum lamina propria of B6 mice fed with ND (n= 9) or HFD (n= 8), and Vα19+/− (ND/HFD n= 14/10) and
MR1−/− (ND/HFD n= 10/14) mice and their respective littermate controls (Vα19−/− ND/HFD n= 16/11 and MR1+/− ND/HFD n= 10/11) after 12 weeks
of HFD or ND feeding. Pooled data from two or three experiments are represented. c Kinetic analysis of Foxp3+ Treg cells among CD45+ cells of Vα19+/−
and MR1−/− mice and their respective littermate controls (Vα19−/− and MR1+/−) fed ND or HFD during 3, 6, and 12 weeks (n= 8 per group for each
time). d FITC-dextran assay in Vα19+/− and MR1−/− mice and their littermate controls (n= 10 per group) fed HFD for 12 weeks. e Relative quantity of
ZO-1, Cldn4, Ocln, and mucin transcripts in ileum epithelial cells of Vα19+/−, MR1−/−, and their respective littermate controls fed on HFD for 12 weeks
(n= 6 per group). f, g Significant differences at the (f) phyla, (g) family levels between gut microbium of Vα19−/− (n= 13) and Vα19+/− (n= 12) HFD-fed
mice. h Heatmap showing the significant differences between the OTU clusters of the Vα19−/− (n= 13) and Vα19+/− (n= 12) mice microbiota. Significant
differences in (i) Actinobacteria phyla, (j) Coriobacteriaceae family and related Olsenella (genus), and (k) in the Clostridiaceae family and related genus
between the MR1+/− (n= 13) and MR1−/− (n= 12) mice microbiota. l Heatmap showing OTU clusters abundance between MR1+/− (n= 13) and MR1−/−
(n= 12) mice gut microbiota. Data in f, g, i, j, and k are presented as boxplots where the middle line is the median, the lower and upper hinges correspond
to the first and third quartiles, the upper whisker extends from the hinge to the largest value no further than 1.5 × IQR from the hinge (where IQR is the
inter-quartile range), and the lower whisker extends from the hinge to the smallest value at most 1.5 × IQR of the hinge. The fold change and the P-value of
a Mann–Whitney test are indicated as mean ± S.E.M. For b and d, each symbol represents an individual mouse (small horizontal lines indicate the mean ± S.
E.M.). In a, c and e, data are represented as mean ± S.E.M.. All statistical analyses were performed by two-tailed Mann–Whitney test. *P < 0.05, **P < 0.01,
***P < 0.001 (see also Supplementary Figs. 12, 13).
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Plasma triglycerides and glycerol release were measured using the colorimetric
diagnostic kit, according to the manufacturer’s instructions (Randox Laboratories).
For insulin-signaling assays, mice were fasted for 6 h and then i.p. injected with
1.00 U/kg insulin. Mice were euthanized after 15 min, and liver, Epi-AT, and
muscle were collected for western blot analysis.
Lean tissue and fat mass were measured using an Echo Medical systems’
EchoMRI 100 (Whole Body Composition Analyzers, EchoMRI, Houston, USA),
according to the manufacturer’s instructions.
In vivo analysis of intestinal permeability. In vivo intestinal permeability was
evaluated by the intestinal permeability of FITC-dextran 4 kDa. Briefly, 6-h water-
fasted mice were gavaged with FITC-dextran 4 kDa by gavage (600 mg/kg body
weight, 120 mg/ml; Sigma-Aldrich, St Louis, MO). After 4 h, 120 μl of blood were
collected from each mouse from the retro-orbital vein. The blood was centrifuged
at 4 °C, 10,000 rpm, for 5 min. Plasma was analyzed for FITC-dextran 4 kDa
concentration with a fluorescence spectrophotometer (SPARK 10M, TECAN) at
excitation and emission wavelengths of 485 nm and 535 nm, respectively. Standard
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curves for calculating the FITC-dextran 4 kDa concentration in the samples were
obtained by diluting FITC-dextran 4 kDa in PBS.
Western blot. Samples were lysed in RIPA buffer (Sigma ref# R0278-50ML)
supplemented with protease (Sigma ref# S8820-2TAB) and phosphatase (Roche
ref# 001,04,845,906) inhibitors, and were diluted to a concentration of 20 μg of
protein and heated at 98 °C for 10 min. Proteins were separated by SDS–PAGE
electrophoresis and transferred to nitrocellulose membranes (Bio-Rad ref#
1620168). Blocking reagent (TBS with 0.5% Tween 20 and 3% BSA, pH 7.4) were
incubated for 1 h, and primary antibody was incubated overnight at 4 °C in the
blocking solution. The antibodies and their concentrations are the following: anti-
phospho-AKT (Cell signaling, 9331S; 1:2000), anti-AKT (Cell signaling, 9272S;
1:2000). After several washes in PBS with 0.5% Tween 20, horseradish peroxidase
(HRP)-labeled secondary antibodies (1:5000) were incubated for 1 h at room
temperature in the blocking solution. Membranes were incubated with ECL
western-blotting substrate (Bio-Rad ref# 170–5060) and imaged by the myECL
Imager (ThermoFisher, 62236). Blots were semi-quantified using ImageJ software.
MAIT cell and macrophage co-culture. MAIT cells were isolated from the spleen
of Vα19 Tg Cα−/− mice as described above. In some experiments, MAIT cells were
pre-activated O.N. using Dynabeads Mouse T-Activator CD3/CD28 (Gibco,
11453D) following the manufacturer instructions. BMDMs were isolated from WT
or Mr1−/− C57BL6/J male mice. Mice were euthanized, and the bone marrow from
their femur and tibias was collected. BMDMs (2 × 105 cells/well) were cultured and
differentiated for 7–10 days, in RPMI 1640 medium (Gibco, 6187-010) supple-
mented with 10% FCS, 1% penicillin/streptomycin, and 50 ng/ml MCSF (Miltenyi
Biotec, 130-101-706). M0 macrophages were co-cultured with activated or non-
activated MAIT cells (2 × 105 cells/well) for 72 h prior to FACS analysis. In some
experiments, 10 μg/ml of cytokine-neutralizing antibodies (anti-IL-17, anti-IFNγ,
or anti-TNFα) were added to the culture media. In another set of experiments, in
vitro-differentiated macrophages were either kept in their M0 state or further
differentiated for 48 h into M1 macrophages by replacing MCSF by 25 ng/ml of
recombinant IFNγ (Miltenyi Biotec, 130-105-785) or M2 macrophages by repla-
cing MCSF by 20 ng/ml of recombinant IL-4 (Miltenyi Biotec, 130-097-757).
Differentiation of BMDM into M0, M1, or M2 macrophages was similar in WT
and Mr1−/− mice as validated by qPCR of characteristic genes. M0, M1, and M2
macrophages were co-cultured with purified MAIT cells for 48 h prior to FACS
analysis.
MAIT cell ligands in cecum contents. Cecum contents were recovered, weighted,
and half of each sample was resuspended in PBS (the other half was kept for the
metagenomic analyses). After homogenization, supernatants were centrifuged at
14,000 rpm for 5 min at 4 °C and were passed through a 0.22-μm filter. Super-
natants were tested at final concentration of 1.5 mg intestinal content per ml, and
serial dilutions of 5-OP-RU were used as a positive control. Two bioassays were
performed in Cochin Institute and Melbourne University, respectively. In Cochin
Institute, WT3-MR1 cell line (mycoplasma free) was used to detect MAIT cell
ligand from intestinal contents56. Two hours before the experiment, WT3-MR1
cells were coated onto a 96-flat-well plate at final concentration of 0.5 × 106 per ml
in medium containing DMEM Glutamax 10% FCS, 1M HEPES; 100 mM sodium
pyruvate, 1% nonessential amino acids and 1% penicillin–streptomycin.
MAIT cells were isolated from the spleen of Vα19 Tg Cα−/− mice as described
above and were co-cultured with WT3-MR1 cells at final concentration of 5 × 105
MAIT cells per ml. Acetyl-6-FP (10 μM) was added to determine MR1-specific
activation. One day later, MAIT cells were stained with the appropriate antibodies,
and activation was analyzed by flow cytometry.
The second bioassay is based on the activation of Jurkat.MAIT cells. MAIT cell
reporter activation and MR1 surface expression upregulation assays were
performed essentially as previously reported34,71. Jurkat cells overexpressing the
MAIT TCR clone AF-7 (Jurkat.MAIT), or an HLA-B8-EBV peptide-specific non-
MAIT control TCR (Jurkat.LC13) were tested for activation by co-incubation with
10 μl colonic extracts from individual mice, or 0.1 nM 5-OP-RU (positive control)
and C1R cells overexpressing MR1 (CIR.MR1) for ~16 h. Cells were subsequently
stained with PE-Cy7-conjugated anti-CD3 (UCHT1, eBioscience, 1:300), APC-
conjugated anti-CD69 (BD, 1:25), and 7-aminoactinomycin D (7AAD) before
analysis by on a FACS CantoII (BD) flow cytometer. Activation of Jurkat.
MAIT cells (defined as CD3+, 7AAD−, and separated from C1R.MR1 cells based
on GFP expression) was measured by an increase in surface CD69 expression.
Jurkat.LC13 cells co-cultured with C1R cells expressing HLA-B8 in the presence of
the Epstein–Barr viral peptide FLRGRAYGL (FLR) was included as a positive
control for their activation. For blocking, C1R.MR1 cells were first incubated with
anti-MR1 mAb 26.556 or isotype control mAb W6/3272, both purified in house, at
20 μg/ml for 1 h, prior to addition of Jurkat cells and test samples.
Neonatal transfer of microbiota. Weaned B6 males (aged 21–26 days) were
gavage with diluted fecal contents from adult 11–20-week-old males, according to a
previous study73 with slight modifications. Briefly, the fresh feces from adult donor
mice were collected in a sterile tube, and the contents were mixed to 50 volumes of
sterile water, then 250 μL of this suspension was given to each recipient mouse by
oral gavage using a 24-G round-tip gavage needle. Recipients were rested for 24 h,
and this procedure was repeated once. Moreover, to strengthen transfer of
microbiota efficacy, we gave “fecal water”, from the same donor groups to the same
recipient groups, twice a week during 8–10 weeks.
Ac-6-FP treatment. Vα19+/− mice fed during 6 weeks of HFD were then giving
water ad libitum containing 50 nM/ml of Ac-6-FP (Acetyl-6-formylpterin) or PBS
for the following 8 weeks of HFD and intraperitoneally injected with a total volume
of 200 μl containing 50 nM of Ac-6-FP or 200 μl of PBS, twice a week. ITT and
OGTT were performed 6 weeks after the beginning of the treatment. At 8 weeks of
treatment, mice were scarified prior to analysis.
Statistical analysis. All statistical tests were performed using GraphPad Prism
8.3.0 (GraphPad Software, Inc., La Jolla, CA), and all data were represented as
mean ± S.E.M. Statistical tests were assessed after confirming that the data met
appropriate assumptions (normality, homogenous variance, and independent
sampling). Gaussian distribution was tested using the Kolmogorov–Smirnov test.
Group comparisons were assessed with Mann–Whitney, Student’s t or ANOVA
tests to compare groups. All statistical tests were two-tailed, and P < 0.05 was
defined as significant.
Histology. Epi-AT and ileum samples were fixed in 3% formaldehyde solution
overnight and embedded in paraffin. Epi-AT slides were stained with hematoxylin
and eosin for the evaluation of the tissue morphology, following standardized
protocols. Adipocyte size was measured by the diameters of the adipocytes in light-
microscopy images (×20) of Epi-AT sections (= 50 adipocytes per section, three
sections per mouse, six mice per group), and analyzed using ImageJ software.
Bacteria 16S sequencing and bioinformatics analysis. 16S sequencing analyses
were performed on feces. Read pairs were quality filtered, adapter-trimmed, and
merged using Flash1.6.274. PCR primers were then removed, and sequences with
sequencing errors were excluded (Mothur)75. In total, 15000 reads were randomly
selected for each sample. Merged read pairs were demultiplexed using QIIME, and
clustered into operational taxonomic units (OTUs). Chimera were removed using
UCHIME76 and Mothur75 softwares. A sequence similarity threshold of 97% was
Fig. 7 MAIT cells impact on microbiota, gut mucosa and adipose tissue fecal transplanted or co-housed mice. a Flowchart illustrating feces transfer
procedure and data-analysis workflow. b Heatmap showing the significant differences in OTU clusters abundance between recipient mice T-MR1+/− that
received microbiota from obese MR1+/− mice and the T-MR1−/− mice that received microbiota from obese MR1−/−. c Significant differences at the genus
level between the microbiota of recipient mice T-Vα19−/− (n= 12) (microbiota from obese Vα19−/− mice) and the T-Vα19+/− (n= 11) (microbiota from
obese Vα19+/−). d Heatmap showing the significant differences between the OTU clusters of the T-Vα19−/− and T-Vα19+/− mice microbiota. e Intestinal
permeability measured by FITC-dextran assay (n= 6/group). f, g Graphs showing the frequency of immune cells in the ileum (f) and Epi-AT (g) of
T-Vα19−/− (n= 10), T-Vα19+/− (n= 10), T-MR1+/− (n= 10) and T-MR1−/− (n= 10). h Graphs showing the frequency of Foxp3+ Treg cells and ILC3
among CD45+ cells in the ileum lamina propria (n= 9 mice/group). i Graphs showing the frequency of eosinophils among CD45+ cells in the Epi-AT
stroma-vascular fraction (SVF) (n= 9 mice/group). j Graphs showing the frequency of total Epi-AT macrophages among CD45+, of M2 and M1 subsets
among total Epi-AT macrophages and M1/M2 macrophage ratio (n= 9 mice/group. k Graphs showing the relative quantity of pro-inflammatory M1
markers (Ccr2, Mcp1, Il1β, Il6, and Tnfα) and anti-inflammatory M2 markers (Tgfbr2, Cd206, Cd163, and Il10) transcripts in Epi-AT macrophages from
Vα19+/− (n= 6) and MR1−/− (n= 6) mice co-housed with their respective littermate controls (Vα19−/− n= 6 and MR1+/− n= 5) and fed on HFD during
12 weeks. Data in d are presented as boxplots, as mean ± S.E.M.. For e, f, and h–j, each symbol represents an individual mouse (small horizontal lines
indicate the mean ± S.E.M.). In k, data are represented as mean ± S.E.M.. All statistical analyses were performed by two-tailed Mann–Whitney test.
*P < 0.05, **P < 0.01, ***P < 0.001 (see also Supplementary Fig. 14).
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used to assign reads to OTUs against the Greengenes database (release 13-5)77 and
RDP classifier78.
Following rarefaction of all communities to even sampling depths, the
abundances of all families were computed by agglomerating the OTUs assigned to
those families. For each family, Mann–Whitney test with BH correction79 were
carried out to identify the combinations (treatment) that were significantly
different in terms of abundance. The same method was used for each genus. All
analyses were done using R package (R Core Team, 2015, R Foundation for
Statistical Computing, Vienna, Austria). Statistical analyses were performed using
non-parametric Mann–Whitney U test. The results were considered statistically
significant when P-values were lower than 0.05.
Metagenomic analysis. Metagenomic analyses were performed on cecum con-
tent from the same samples used for the bioassays. A set of 18 KEGG modules
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Fig. 8 Ac-6-FP treatment during HFD improved metabolic parameters. a, b ITT and OGTT at 12 weeks of HFD in Vα19+/− (n= 7) (a) or B6 WT (n= 6)
(b) Ac-6-FP-treated mice and their respective controls. c Graph showing the relative quantity of Il6, Il17, and Tnfα transcripts in the ileum of Ac-6-FP-
treated Vα19+/− (n= 8) mice and Vα19+/− (n= 7) control mice. d Graph showing the relative quantity of Atgl, Hsl, Ccl2, Il1β, Il6, Il17, and Tnfα in Epi-AT of
Ac-6-FP-treated Vα19+/− (n= 8) mice and Vα19+/− (n= 7) control mice. e MAIT cells frequency among αβT cells in Vα19+/− (n= 6) or B6 WT (n= 6)
Ac-6-FP-treated mice and their respective controls. f, g show representative histograms of CD69 surface marker staining on MAIT cells from the ileum and
Epi-AT of in Vα19+/− (n= 6) (f) or B6 WT (n= 6) (g) Ac-6-FP-treated mice. h Intracellular staining of MAIT cells for IL-17A. Frequency of positive
MAIT cells from the ileum and Epi-AT of Vα19+/− control (PBS) (n= 5) and Vα19+/− Ac-6-FP-treated (n= 5) mice are indicated. I, j The frequency of
Epi-At macrophages among CD45+ cells. Data showing the frequency of M1 macrophages (CD206−CD11c+) and M2 macrophages (CD206+CD11c−)
among total Epi-AT macrophages and M1/M2 ratio in Vα19+/− (n= 6) (i) or B6 WT (n= 5) (j) Ac-6-FP-treated mice and their respective controls.
k Actinobacteria, Bacteroidetes, and Firmicutes relative DNA expression compared with UTB. Bacterial DNA was extracted from cecum fecal content of
Ac-6-FP-treated Vα19+/− (n= 8) mice and Vα19+/− (n= 7) control mice. In a–d, all data are represented as mean ± S.E.M.. For e–k, each symbol
represents an individual mouse (small horizontal lines indicate the mean ± S.E.M.). All statistical analyses were performed by two-tailed Mann–Whitney
test. *P < 0.05, **P < 0.01, ***P < 0.001. (See also Supplementary Fig. 15).
Table 1 List of antibodies and reagents.
Antibodies
PerCP-Cy5.5 rat anti-mouse CD45 (30-F11) (1/100) BD Biosciences 550994
APC/Cy7 anti-mouse CD45 (30-F11) (1/100) Biolegend 103116
BD Horizon™ BV711 anti-mouse TCR β chain (H57) (1/100) BD Biosciences 563135
BD Horizon™ BV421 anti-mouse TCR β chain (H57) (1/100) BD Biosciences 562839
Brilliant Violet 605 anti-mouse CD8a (53-6.7) (1/100) Biolegend 100743
Alexa Fluor 700 anti-mouse CD8α (53-6.7) (1/100) eBioscience 56-0081-82
PE-Cyanine7 anti-mouse CD8α (53-6.7) (1/100) eBioscience 25-0081-82
BD Horizon™ BV421 anti-mouse CD103 (M290) (1/100) BD Biosciences 562771
Alexa Fluor 700 anti-mouse CD44 (IM7) (1/100) eBioscience 56-0441-82
Brilliant Violet 785 anti-mouse CD45.1 (A20) (1/100) Biolegend 110743
APC anti-mouse CD45.2 (104) (1/100) Biolegend 109814
Brilliant Violet 711 anti-mouse Ly-6A/E (Sca-1) (D7) (1/100) Biolegend 108131
Brilliant Violet 510 anti-mouse NK1.1 (PK136) (1/100) Biolegend 108737
Brilliant Violet 650 anti-mouse CD19 (6D5) (1/100) Biolegend 115541
Brilliant Violet 510 anti-mouse CD4 (GK1.5) (1/100) Biolegend 100449
Brilliant Violet 785 anti-mouse/human CD11b (M1/70) (1/100) Biolegend 101243
PE/Cy5 anti-mouse CD127 (IL-7Ralpha) (A7R34) (1/100) Biolegend 135016
PerCP/Cy5.5 anti-mouse CD25 (PC61) (1/100) Biolegend 102029
Brilliant Violet 605 anti-mouse CD69 (HI-2F3) (1/100) Biolegend 104530
PE anti-mouse CD11c (N418) (1/100) Biolegend 117308
PerCP-eFluor 710 anti-mouse CD170 (Siglec-F) (IRNM44N) (1/100) eBioscience 46-1702-80
PE-Cyanine 7anti-mouse F4/80 (BM8) (1/100) eBioscience 25-4801-82
APC anti-mouse TCRγδ (GL-3) (1/100) eBioscience 17-5711-82
PE anti-mouse FOXP3 (FJK-16s) (1/100) eBioscience 12-5773-82
PE-eFluor 610 anti-mouse ROR γE-e (Β2Δ) (1/100) eBioscience 61-6981-80
PerCP/Cy5.5 anti-mouse PLZF (9E12) (1/100) Biolegend 145807
Brilliant Violet 60 anti-mouse T-bet (4B10) (1/100) Biolegend 644817
Brillant Viollet 450 anti-mouse Ki67 (SolA15) (1/100) eBioscience 48569882
PE anti-mouse CD206 (C068C2) (1/100) Biolegend 141706
PE-CF594 anti-mouse CX3CR1 (SA011F11) (1/100) Biolegend 149014
Alexa Fluor 700 anti-mouse CD11c (N418) (1/100) eBioscience 56-0114-82
Alexa Fluor 647 anti-mouse Bcl-2 (BCL/10C4) (1/100) Biolegend 633509
eFluor450 anti-mouse TNFα (MP6-XT22) (1/100) eBioscience 48-7321-82
Alexa Fluor 700 anti-mouse IFN-γ (XMG1.2) (1/100) BD Biosciences 557998
PerCP-Cy5.5 anti-mouse IL-17A (TC11-18H10) (1/100) BD Biosciences 560666
anti-Akt (polyclonal) (1/2000) Cell signaling 9272S
anti-pAkt (polyclonal) (1/2000) Cell signaling 9331S
BD Via-Probe™ cell viability solution (1/500) BD Biosciences 555815
Critical commercial assays
TRIGS RANDOX TR210
GLY RANDOX GY 105
Ultra-sensitive mouse insulin ELISA kit Crystal Chem 90080
Lamina propria dissociation kit Miltenyi 130-097-410
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was identified within the “Cofactor and vitamin biosynthesis” category. Abun-
dance of each KEGG module in the sample was calculated as the number of read
pairs mapping to all genes annotated to a given KEGG module, divided by the
total number of mapped read pairs. Further, KEGG Orthologs (KOs) involved in
menaquinone, NAD, tetrahydrofolate, and riboflavin biosynthesis were extrac-
ted. KEGG Ortholog abundance is defined as the number of read pairs mapping
to all genes annotated to a given KEGG ortholog, divided by the total number of
mapped read pairs. Statistical comparisons between groups were performed
using two-sided Wilcoxon rank-sum test. Where multiple hypotheses were
evaluated in parallel, the Benjamini–Hochberg method was used to control false
discovery rate.
Reporting summary. Further information on research design is available in the Nature
Research Life Sciences Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available in figshare with the identifier
doi: 10.6084/m9.figshare.12490271 and in the Source Data file. All data are available from
the corresponding authors upon reasonable request. Source data are provided with
this paper.
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